Jane Street’s Meridian Bioscience Inc VIVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-37,031
| Closed | -$1.23M | – | 10539 |
|
|
2022
Q4 | $1.23M | Buy |
37,031
+21,869
| +144% | +$704K | ﹤0.01% | 4648 |
|
|
2022
Q3 | $478K | Buy |
15,162
+4,350
| +40% | +$141K | ﹤0.01% | 6770 |
|
|
2022
Q2 | $329K | Sell |
10,812
-15,990
| -60% | -$432K | ﹤0.01% | 7464 |
|
|
2022
Q1 | $696K | Buy |
+26,802
| New | +$638K | ﹤0.01% | 6856 |
|
|
2021
Q3 | – | Sell |
-27,123
| Closed | -$541K | – | 11065 |
|
|
2021
Q2 | $602K | Buy |
27,123
+2,670
| +11% | +$56.6K | ﹤0.01% | 6890 |
|
|
2021
Q1 | $642K | Buy |
+24,453
| New | +$581K | ﹤0.01% | 6339 |
|
|
2020
Q4 | – | Sell |
-21,394
| Closed | -$399K | – | 8346 |
|
|
2020
Q3 | $363K | Sell |
21,394
-11,395
| -35% | -$221K | ﹤0.01% | 5615 |
|
|
2020
Q2 | $764K | Buy |
32,789
+15,357
| +88% | +$223K | ﹤0.01% | 4466 |
|
|
2020
Q1 | $146K | Buy |
+17,432
| New | +$147K | ﹤0.01% | 4790 |
|
|
2018
Q1 | – | Sell |
-10,011
| Closed | -$140K | – | 5606 |
|
|
2017
Q4 | $140K | Buy |
+10,011
| New | +$147K | ﹤0.01% | 4295 |
|
|
2013
Q3 | – | Sell |
-15,122
| Closed | -$325K | – | 3235 |
|
|
2013
Q2 | $325K | Buy |
+15,122
| New | +$326K | 0.01% | 1820 |
|
Other funds holding VIVO
Jane Street's VIVO Position: Q1 2023 in Review
Jane Street sold out of Meridian Bioscience Inc (VIVO) in Q1 2023, closing a stake of 37,031 shares — an estimated $1.23M sold.
Jane Street first reported a position in VIVO in Q2 2013 and held it in 11 quarters. The position peaked at $1.23M in Q4 2022. 2 funds tracked by Wall St. Rank hold VIVO as of Q1 2023.
- Jane Street reported no remaining Meridian Bioscience Inc position as of Q1 2023 after selling out during the quarter.
- Jane Street sold 37,031 Meridian Bioscience Inc shares in Q1 2023, an estimated $1.23M.
- Jane Street first reported a position in Meridian Bioscience Inc in Q2 2013 and held it in 11 quarters.
- Jane Street's Meridian Bioscience Inc position peaked at $1.23M in Q4 2022.
- 2 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2023.
Based on Jane Street's 13F filing for Q1 2023, filed 16 May 2023.